SCALONE, LUCIANA
 Distribuzione geografica
Continente #
NA - Nord America 6.716
AS - Asia 3.849
EU - Europa 3.189
SA - Sud America 598
AF - Africa 103
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.470
Nazione #
US - Stati Uniti d'America 6.306
SG - Singapore 1.686
CN - Cina 729
IT - Italia 563
DE - Germania 508
RU - Federazione Russa 463
BR - Brasile 457
HK - Hong Kong 452
VN - Vietnam 396
SE - Svezia 390
CA - Canada 370
IE - Irlanda 302
UA - Ucraina 237
GB - Regno Unito 183
IN - India 145
FR - Francia 121
AT - Austria 91
FI - Finlandia 80
DK - Danimarca 78
BD - Bangladesh 66
TR - Turchia 55
AR - Argentina 49
NL - Olanda 41
PK - Pakistan 41
IQ - Iraq 37
ID - Indonesia 36
ZA - Sudafrica 35
ES - Italia 32
KR - Corea 30
JP - Giappone 28
MX - Messico 26
BE - Belgio 23
EC - Ecuador 22
VE - Venezuela 22
PH - Filippine 21
SA - Arabia Saudita 21
PL - Polonia 19
AE - Emirati Arabi Uniti 18
CO - Colombia 18
KE - Kenya 14
CL - Cile 12
CH - Svizzera 10
UZ - Uzbekistan 10
DZ - Algeria 9
IR - Iran 9
CZ - Repubblica Ceca 8
MA - Marocco 7
TH - Thailandia 7
TN - Tunisia 7
TW - Taiwan 7
AU - Australia 6
AZ - Azerbaigian 6
BG - Bulgaria 6
ET - Etiopia 6
JO - Giordania 6
PY - Paraguay 6
RS - Serbia 6
BO - Bolivia 5
EG - Egitto 5
LB - Libano 5
BH - Bahrain 4
EU - Europa 4
LT - Lituania 4
MN - Mongolia 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
RO - Romania 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
SN - Senegal 3
AL - Albania 2
AO - Angola 2
BF - Burkina Faso 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
MZ - Mozambico 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
UY - Uruguay 2
ZM - Zambia 2
A1 - Anonimo 1
BB - Barbados 1
BT - Bhutan 1
BW - Botswana 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
Totale 14.453
Città #
Singapore 744
Ann Arbor 700
Ashburn 533
Woodbridge 491
Hong Kong 443
San Jose 406
Chandler 368
Fairfield 344
Houston 312
Frankfurt am Main 292
Dublin 286
Toronto 272
Jacksonville 231
Wilmington 226
Dearborn 194
New York 189
Seattle 143
Santa Clara 142
Milan 138
Princeton 128
Beijing 122
Cambridge 116
Ho Chi Minh City 113
Dallas 108
The Dalles 105
Chicago 97
Hanoi 92
Los Angeles 88
Vienna 85
Nanjing 66
Altamura 57
Lauterbourg 56
Lawrence 54
Shanghai 54
Council Bluffs 45
Rome 44
Moscow 41
Lachine 37
Helsinki 36
São Paulo 36
Buffalo 35
Guangzhou 34
Fremont 33
Orem 33
San Diego 26
Shenyang 23
Tianjin 22
Andover 21
Columbus 21
Haiphong 21
Hefei 21
Jakarta 21
London 21
Ottawa 21
Munich 20
Seoul 20
Tokyo 20
Changsha 18
Da Nang 18
Dong Ket 18
Jinan 18
Johannesburg 18
Boston 17
Nanchang 17
Brussels 16
Hebei 16
Lahore 16
Jiaxing 15
Baghdad 13
Boardman 13
Brooklyn 13
Manchester 13
Salt Lake City 13
Brasília 12
Nairobi 12
Zhengzhou 12
Dhaka 11
Mountain View 11
Mumbai 11
Phoenix 11
Warsaw 11
Chennai 10
Ningbo 10
Redmond 10
San Francisco 10
Tashkent 10
Valencia 10
Belo Horizonte 9
Hangzhou 9
Montreal 9
Rio de Janeiro 9
Amsterdam 8
Atlanta 8
Bonndorf 8
Delhi 8
Falls Church 8
Guayaquil 8
Hải Dương 8
Jeddah 8
Karachi 8
Totale 8.958
Nome #
Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population 460
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 448
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 383
Use of health care administrative databases to estimate the burden of breast cancer. 355
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 351
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 348
Health related quality of life in chronic liver diseases 320
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 309
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 308
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 303
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 296
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 295
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 295
The impact of liver disease on the health-related quality of life 291
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 282
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 281
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 281
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 278
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 275
Sustainability of the Italian National Health Service 269
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 268
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 268
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 267
Health Related Quality of Life in the Major Liver Conditions 265
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 261
Difference in health related quality of life of chronic liver diseases and general population 256
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 255
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 254
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 249
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 248
Health related quality of life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments 243
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 234
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 230
Il burden delle polmoniti: analisi dai database amministrativi (DENALI) della regione Lombardia. 227
Development of a segmentation model to identify healthcare demand and related costs attributable to population's characteristics 221
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases 218
Utilization of disease modifying agents in multiple sclerosis: from an Italian administrative database. 217
Italian population-based values of EQ-5D health states 215
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases 214
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: Results from Italy 207
Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens 207
Analisi della domanda di salute attraverso l’impiego di database amministrativi regionali 203
Use of health care administrative databases to estimate incidence of foot complications in diabetes patients 193
Obsessive compulsive tic disorder: Appropriate diagnosis and treatment as key elements to improve health and rationalize use of resources 191
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: The COCIS study group 190
Utilization of antispasticity drugs in multiple sclerosis: analysis from an Italian administrative database 186
Use of healthcare administrative databases to estimate the burden of diabaetes mellitus: a population-based study 185
Impatto dei trend demografici ed epidemiologici sulla sostenibilità del SSN. 174
Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study 170
Use of health care administrative databases to estimate the health care burden of bone or bone marrow metastatic disease in breast cancer patients: a population-based study. 164
Use of health care administrative databases to estimate the burden of diabetes mellitus: a population-based study 157
Regarding "exploring patient involvement in decision making for vascular procedures" 152
The societal burden of chronic liver diseases: Results from the COME study 150
Use of health-related quality-of-life measurements to estimate individuals' health on screening 148
Patient Preferences and Willingness to Pay for different Options of Anticoagulant Therapy 147
Clinical use, quality of life and cost-effectiveness of spinal cord stimulation used to treat patients with failed back surgery syndrome 143
Use of health care administrative databases to estimate the health care burden of bone or bone marrow metastatic disease in breast cancer patients: a population-based study 136
Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids 133
Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study 132
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: A discrete choice experiment 125
Cost-effectiveness analysis of new drugs for chronic hepatitis C: The importance of updating utility values 124
Preferences of patients, their family caregivers and vascular surgeons in the choice of abdominal aortic aneurysms treatment options: The PREFER study 113
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors: Results from the COHIBA Study 108
Totale 14.876
Categoria #
all - tutte 48.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 0 0 0 0 0 0 0 0 71 67
2021/2022711 39 59 88 68 37 62 28 60 43 48 49 130
2022/20231.451 156 493 130 123 77 217 11 90 87 5 45 17
2023/2024890 32 30 26 49 98 258 168 20 81 11 10 107
2024/20252.444 131 221 124 96 205 101 155 54 291 307 337 422
2025/20264.756 558 228 378 426 541 260 799 247 456 492 371 0
Totale 14.876